A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat

Overview of attention for article published in PLOS ONE, October 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 82,995 followers.

$SHPG - Fibrotech claims FT011 (tranilast analogues) inhibits both TGF-ß and PDGF signaling. http://t.co/xi7HyCZzTG http://t.co/FqnotiCWDA

$SHPG - Fibrotech claims FT011 (tranilast analogues) inhibits both TGF-ß and PDGF signaling. http://t.co/xi7HyCZzTG http://t.co/FqnotiCWDA

$SHPG - Fibrotech claims FT011 (tranilast analogues) inhibits both TGF-ß and PDGF signaling. http://t.co/xi7HyCZzTG http://t.co/FqnotiCWDA